Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

Clinical trial NCT03276468 · COMPLETED

Trial details

NCT number: NCT03276468
Sponsor: The Lymphoma Academic Research Organisation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Diffuse Large B Cell Lymphoma Marginal Zone Lymphoma Mucosa Associated Lymphoid Tissue

Start date: 2018-02-12
Primary completion: 2019-09-19
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.